Description
Introduction of Vivitra 150mg Injection:
Vivitra 150mg Injection is a targeted anticancer medicine used to treat HER2-positive breast cancer and HER2-positive stomach (gastric) cancer. Its active ingredient is trastuzumab. It is a monoclonal antibody, which is a protein made to attach to a specific target on cancer cells.
Vivitra 150mg Injection is supplied as a powder that must be dissolved and diluted before use. It is for intravenous (IV) infusion only, and it must be given by a doctor or a trained healthcare professional in a hospital or clinic, where you will be watched for allergic and infusion reactions. It is usually given once every 3 weeks or once a week.
Your doctor will decide the dose based on your body weight and the condition being treated, and it may change from time to time. Your doctor will also test your tumor for HER2 before starting this medicine, and will check your heart function before and during treatment. Do not stop treatment unless your doctor tells you to. Use effective contraception during treatment and for several months after the last dose, as this medicine can harm an unborn baby.
Fever, chills, headache, nausea, diarrhea, and tiredness are among the most common side effects of this medicine, especially during the first infusion. It can also weaken the heart muscle, so regular heart scans are required, and it can affect the lungs and lower blood cell counts. Inform your doctor if you have heart disease, high blood pressure, or lung problems. Inform your doctor immediately if you experience shortness of breath, swelling of the legs or ankles, a fast or irregular heartbeat, chest pain, sudden cough, fever or chills, wheezing, swelling of the face or lips, or dizziness.
Uses of Vivitra 150mg Injection:
- HER2-positive early breast cancer
- HER2-positive metastatic breast cancer
- HER2-positive metastatic stomach (gastric) cancer or cancer of the gastroesophageal junction, in combination with chemotherapy
Benefits of Vivitra 150mg Injection:
1. HER2-positive breast cancer
In some breast cancers, the cells make too much of a protein called HER2, which makes the cancer grow and spread quickly. Vivitra 150mg Injection blocks this protein, which helps to slow or stop the growth of the cancer and lowers the chance of the cancer coming back after surgery.
2. HER2-positive stomach cancer
In advanced stomach cancer with high HER2, Vivitra 150mg Injection is given together with chemotherapy. It helps to slow the growth of the cancer and may help patients live longer.
3. Targeted treatment
Vivitra 150mg Injection acts mainly on cells that have too much HER2, so it spares many healthy cells compared with standard chemotherapy.
4. Works with chemotherapy
Vivitra 150mg Injection can be given together with chemotherapy, which makes the treatment more effective than chemotherapy alone in HER2-positive cancers.
Side Effects of Vivitra 150mg Injection:
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you are worried about them.
Common side effects of Vivitra 150mg Injection:
- Fever and chills during or after the infusion
- Headache
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Skin rash
- Cough
- Shortness of breath
- Muscle and joint pain
- Difficulty sleeping
- Low white blood cell counts (neutropenia)
- Low red blood cell counts (anemia)
- Infections
- Reduced pumping function of the heart
Mechanism of Action of Vivitra 150mg Injection:
Vivitra 150mg Injection is a monoclonal antibody that targets the HER2 receptor. Its active ingredient, trastuzumab, attaches to HER2 on the surface of cancer cells. This blocks the signals that tell the cells to grow and divide, and it also marks the cancer cells so that the body’s immune cells can find and destroy them. This is how it works against HER2-positive breast and stomach cancer.
Reviews
There are no reviews yet.